(function(){
			var content_array=[" \n<p><b>Boehringer Ingelheim and Eli Lilly and Company <br \/><\/b>In <span class=\"xn-chron\">January 2011<\/span>, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in diabetes that centers on compounds representing several of the largest diabetes treatment classes. The alliance leverages the strengths of two of the world's leading pharmaceutical companies. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at <a href=\"http:\/\/www.boehringer-ingelheim.com\/\" target=\"_blank\" rel=\"nofollow\">www.boehringer-ingelheim.com<\/a> or <a href=\"http:\/\/www.lilly.com\/\" target=\"_blank\" rel=\"nofollow\">www.lilly.com<\/a>.<\/p> \n<p><b>About Boehringer Ingelheim <br \/><\/b>The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, <span class=\"xn-location\">Germany<\/span>, Boehringer Ingelheim operates globally with 142 affiliates and a total of more than 47,400 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.<\/p> \n<p>Taking social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative &quot;Making more Health&quot; and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.<\/p> \n<p>In 2013, Boehringer Ingelheim achieved net sales of about <span class=\"xn-money\">14.1 billion euros<\/span>. R&amp;D expenditure corresponds to 19.5% of its net sales.<\/p> \n<p>For more information please visit <a href=\"http:\/\/www.boehringer-ingelheim.com\/\" target=\"_blank\" rel=\"nofollow\">www.boehringer-ingelheim.com<\/a>. <\/p> \n<p><b>About Lilly Diabetes <br \/><\/b>Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit <a href=\"http:\/\/www.lillydiabetes.com\/\" target=\"_blank\" rel=\"nofollow\">www.lillydiabetes.com<\/a>.<\/p> \n<p><b>About Eli Lilly and Company <br \/><\/b>Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at <a href=\"http:\/\/www.lilly.com\/\" target=\"_blank\" rel=\"nofollow\">www.lilly.com<\/a> and <a href=\"http:\/\/newsroom.lilly.com\/social-channels\" target=\"_blank\" rel=\"nofollow\">http:\/\/newsroom.lilly.com\/social-channels<\/a>. <\/p> \n<p><i>This press release contains forward-looking statements about LY2963016, an investigational compound that is being studied for type 1 and type 2 diabetes. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that LY2963016 will receive regulatory approvals or prove to be commercially successful. For further discussion of these and other risks and uncertainties, please see Lilly's latest Forms 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.<\/i><\/p> \n<p>Lantus&reg; is a registered trademark of Sanofi. <\/p> \n<p><b>CONTACT: <br \/><\/b><span class=\"xn-person\">Tammy Hull<\/span> <br \/>Communications Manager <br \/>Lilly Diabetes <br \/>Email: <a href=\"mailto:hullta@lilly.com\" target=\"_blank\" rel=\"nofollow\">hullta@lilly.com<\/a> <br \/>Phone: +1 (317) 651-9116<\/p> \n<p><span class=\"xn-person\">Ralph Warsinsky<\/span> <br \/>Corporate Communications <br \/>Boehringer Ingelheim GmbH <br \/>Email: <a href=\"mailto:press@boehringer-ingelheim.com\" target=\"_blank\" rel=\"nofollow\">press@boehringer-ingelheim.com<\/a> <br \/>Phone: +49 178 290 8561<\/p> \n<div> \n <table border=\"0\" cellspacing=\"0\" cellpadding=\"0\" class=\"prntblns\"> \n  <tbody> \n   <tr> \n    <td colspan=\"2\" class=\"prngen2\"> <p class=\"prntac\"><span class=\"prnews_span\">REFERENCES<\/span><\/p> <\/td> \n   <\/tr> \n   <tr> \n    <td colspan=\"2\" class=\"prngen2\"><br \/><\/td> \n   <\/tr> \n   <tr> \n    <td class=\"prngen2\"> <p class=\"prntar\"><span class=\"prnews_span\">1.<\/span><\/p> <\/td> \n    <td class=\"prngen2\"> <p class=\"prnews_p\"><span class=\"prnews_span\">Inzucchi SE, Bergenstal RM, et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Diabetes Care June 2012 vol. 35 no. 6 1364-1379. <\/span><\/p> <\/td> \n   <\/tr> \n   <tr> \n    <td class=\"prngen2\"><br \/><\/td> \n    <td class=\"prngen2\"><br \/><\/td> \n   <\/tr> \n  <\/tbody> \n <\/table> \n<\/div> \n<p>Logo- <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20031219\/LLYLOGO\" target=\"_blank\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20031219\/LLYLOGO<\/a> <br \/>Logo- <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20110825\/DE57898LOGO\" target=\"_blank\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20110825\/DE57898LOGO<\/a> <\/p> \n<p>&nbsp;<\/p> \n<p>&nbsp;<\/p>"];
			$("#dvExtra").html(content_array[0]);})();